[ad_1]
Market Summary
U.S. markets closed the year mixed: the S&P 500 rose about 16% for 2025 while the Nasdaq and Dow lagged late‑session. Year-end selling pushed a short-lived spike in volatility as tech and AI names led gains and then profit-taking. Key catalysts into 2026 include Fed rate-path speculation, Nvidia‑TSMC supply tension and global geopolitical risks.
The White House paused a planned tariff increase on household goods, shifting trade policy near the year end. The move reduces immediate pressure on importers but keeps tariffs in play as a future lever of industrial policy.
Figure of the Day
16% – S&P 500 full-year gain in 2025.
The administration abruptly reversed its push to deploy the National Guard to US cities, announcing withdrawals and abandoning earlier deployment plans. The move reshapes domestic security politics and eases an immediate legal fight over federal troop use.
The Justice Department’s review of files tied to Jeffrey Epstein ballooned, leaving millions of pages still to process. The backlog has political and legal ramifications as deadlines and transparency demands collide.
Bullish
Vanda surges after FDA approval
Vanda Pharmaceuticals rallied after the FDA cleared its motion-sickness drug, lifting the biotech’s stock more than 28% and underscoring pockets of strength in biotech IPOs and approvals.
More on breakingthenews.net
Nvidia is pressing contract maker TSMC to boost production of its H200 AI chips as Chinese demand surges. The scramble underscores supply risks for the AI hardware boom and the geopolitical friction around chip flows.
Beijing staged large-scale military drills around Taiwan, including rocket-force participation, signaling escalation in regional posturing. Taiwan kept forces on high alert as tensions and diplomatic friction increased.
Bearish
Corcept plunges after FDA rejection
Corcept Therapeutics’ shares collapsed after the FDA rejected its drug, triggering a deep sell-off and raising questions about the company’s near-term outlook.
More on barrons.com
The Netherlands’ intervention in a chipmaker has triggered diplomatic blowback and fresh supply-chain uncertainty. Beijing publicly criticized the move as nations squabble over strategic technology assets.
Washington expanded sanctions on firms and vessels tied to Venezuelan oil, intensifying pressure on the Maduro regime. The measures target shipping routes and traders, complicating Caracas’s crude exports.
Regulatory Impact
Tariff hike on furniture delayed by one year; SNAP restrictions on candy and soda take effect in several states; Bulgaria joins the eurozone on Jan. 1; USPS postmark policy updated; federal child-care payment freezes and audits initiated in some states.
Elon Musk said Neuralink will push for mass production and automation of implant surgeries next year, signaling commercialization ambitions. The claims raise regulatory and manufacturing questions as Neuralink scales.
OpenAI’s compensation packages have soared, outstripping pre-IPO peers and reshaping tech pay norms. The firm’s stock-based awards and salaries are fueling debate on talent competition and startup pay structures.
Quote
We will start high-volume production in 2026.
— Elon Musk
U.S. equities posted strong annual gains even as markets slid into year-end losses, reflecting volatility and sector rotation. The final-session weakness masks a broader bullish 2025 driven by tech and AI investments.
Warren Buffett left the CEO role at Berkshire Hathaway, marking the end of an era and triggering succession scrutiny. Investors and managers assess what the transition means for holdings and strategy.
Luxury retail is under stress as Saks Global missed a debt payment and prepares for bankruptcy talks. The liquidity squeeze highlights the retail sector’s uneven recovery and leveraged M&A risks.
A court ordered the administration to fund the CFPB, undercutting attempts to curtail the agency, while the president vetoed bipartisan infrastructure bills. The rulings and vetoes reshape the enforcement and funding landscape for consumer protection and public projects.
China’s AI funding scene stayed hot as Moonshot AI closed a major round and Hong Kong saw a wave of AI IPOs. The listings underscore investor appetite and geopolitically fraught capital flows into Chinese tech.
Year-end funding strains pushed banks to tap the Fed’s standing repo facility at record levels while Fed buying steadied short-term markets. The moves highlighted seasonal liquidity quirks and central bank backstops.
Authorities in the Baltic region detained a vessel suspected of damaging an undersea cable, prompting a security probe into critical infrastructure. Cable outages and investigations raised concerns about hybrid or accidental disruptions to communications.
The chip trade remains volatile: TSMC won a U.S. license to ship gear to Nanjing even as documents revealed a thwarted scheme to smuggle export-controlled Nvidia GPUs into China. The episodes underline enforcement gaps and complex trade routes for advanced semiconductors.
Precious metals capped a blockbuster year even as prices pulled back in the final session, reflecting risk-off flows and margin moves. Gold and silver remain historically strong, driven by macro uncertainty and safe-haven demand.
[ad_2]